Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Spengler

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Journal of Virology|June 1, 1995
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infectionM C Jung, H M Diepolder, U Spengler, et al.
European Journal of Medical Research|August 11, 2006
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversionM Vogel, M Lichterfeld, D E Kaufmann, et al.
The American Journal of Gastroenterology|December 1, 1996
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIVJ K Rockstroh, U Spengler, T Sudhop, et al.
European Journal of Clinical Nutrition|April 1, 1997
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infectionM P Look, J K Rockstroh, G S Rao, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2012
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]C Sarrazin, T Berg, M Cornberg, et al.
AIDS Research and Treatment|August 18, 2012
Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in GermanyE Anadol, S Beckebaum, K Radecke, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|December 17, 2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trialJ Wiegand, H Wedemeyer, A Franke, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Journal of Virology|June 1, 1995
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infectionM C Jung, H M Diepolder, U Spengler, et al.
European Journal of Medical Research|August 11, 2006
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversionM Vogel, M Lichterfeld, D E Kaufmann, et al.
The American Journal of Gastroenterology|December 1, 1996
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIVJ K Rockstroh, U Spengler, T Sudhop, et al.
European Journal of Clinical Nutrition|April 1, 1997
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infectionM P Look, J K Rockstroh, G S Rao, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2012
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]C Sarrazin, T Berg, M Cornberg, et al.
AIDS Research and Treatment|August 18, 2012
Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in GermanyE Anadol, S Beckebaum, K Radecke, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|December 17, 2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trialJ Wiegand, H Wedemeyer, A Franke, et al.
Pageof 20